Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04321512 · ClinicalTrials.gov registry record

Study of Circulating Monocytes in Patients With Ischemic Vascular Disease

A clinical trial of Myocardial Infarction and Stroke, Ischemic, sponsored by UConn Health.

Recruiting
Registry status
300
Enrollment target
1
Study location

NCT04321512 is a study of Myocardial Infarction and Stroke, Ischemic that is actively recruiting participants, run by UConn Health. The registered enrollment target is 300 participants, below the 4,677-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04321512, a study of Myocardial Infarction and Stroke, Ischemic, is actively recruiting participants, sponsored by UConn Health.

RECRUITING
Registry status
300 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to discover the functions of circulating white blood cells, called monocytes, and associated circulating substances in heart attack and ischemic stroke patients. Ischemic Strokes (clots) occur as a result of an obstruction within a blood vessel supplying blood to the brain. A type of monocyte carrying a surface marker called "P2X4" helps the immune system sense and respond to danger signals from the body such as heart muscle and brain tissue injuries. The researchers expect to learn more about how these monocyte cells react to heart and brain tissue injury, and how the cells may then produce proteins or other chemical substances which promote the healing of heart muscle after heart attack and brain tissue after an ischemic stroke.

Conditions Studied

Myocardial Infarction Stroke, Ischemic Ischemia

Interventions

  • OTHER There is no intervention given to the subjects

Study Locations (1)

Connecticut

  • University of Connecticut Health Center - Farmington

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2013-12-01
Est. Completion 2027-12-01

Sponsor

UConn Health

178 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04321512

The ClinicalTrials.gov registry entry for NCT04321512 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,677-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (94% lower). The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Myocardial Infarction appearing as the primary indexed condition, and to 1 intervention - of which There is no intervention given to the subjects is the first listed.

NCT04321512 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT04321512 about?

NCT04321512 is a clinical study titled "Study of Circulating Monocytes in Patients With Ischemic Vascular Disease". The purpose of this research study is to discover the functions of circulating white blood cells, called monocytes, and associated circulating substances in heart attack and ischemic stroke patients. Ischemic Strokes (clots) occur as a result of an obstruction within a blood vessel supplying blood t...

What is the current status of trial NCT04321512?

This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2013-12-01. Estimated completion is 2027-12-01.

What conditions does trial NCT04321512 study?

This clinical trial studies the following conditions: Myocardial Infarction, Stroke, Ischemic, Ischemia.

What interventions are being tested in trial NCT04321512?

The interventions under investigation include: There is no intervention given to the subjects (OTHER).

Who is sponsoring clinical trial NCT04321512?

This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04321512 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myocardial Infarction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Myocardial Infarction

All registered trials for this condition

Stroke, Ischemic

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.